Varex Imaging (FRA:VI4) Cash Flow from Financing: €-200.2 Mil (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:VI4 Varex Imaging Corp FRA:VI4
70 GF Score
Price €10.20
GF Value €11.41
! 3 Warning Signs
View Full Analysis

What is Varex Imaging Cash Flow from Financing?

Varex Imaging FRA:VI4 +5.15% 70 Cash Flow from Financing is €-200.2 Mil as of Mar. 2026. GuruFocus rates FRA:VI4 with a GF Score™ of 70/100 and a GF Value™ of €11.41. The stock has 3 warning signs investors should review.

Cash from financing is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders.

For the three months ended in Mar. 2026, Varex Imaging paid €0.0 Mil more to buy back shares than it received from issuing new shares. It spent €20.1 Mil paying down its debt. It paid €0.0 Mil more to buy back preferred shares than it received from issuing preferred shares. It received €0.0 Mil from paying cash dividends to shareholders. It spent €5.3 Mil on other financial activities. In all, Varex Imaging spent €25.3 Mil on financial activities for the three months ended in Mar. 2026.


Varex Imaging  (FRA:VI4) Cash Flow from Financing Explanation

Cash from financing contains six items:

1. Issuance of Stock:
A company may raise cash from issuing new shares. Issuance of stock represents the cash inflow from offering common stock, which is the additional capital contribution to the entity during the period.

Varex Imaging's issuance of stock for the three months ended in Mar. 2026 was €0.0 Mil.

2. Repurchase of Stock:
A company may raise cash from issuing new shares. It can also use cash to buy back shares. Repurchase of stock represents the cash outflow to reacquire common stock during the period.

Varex Imaging's repurchase of stock for the three months ended in Mar. 2026 was €0.0 Mil.

3. Net Issuance of Debt:
Net issuance of debt is the cash a company received or spent through debt related activities such as debt issuance or debt repayment. If a company pays down its debt during the period, this number will be negative. If a company issued more debt, it receives cash and this number is positive.

Varex Imaging's net issuance of debt for the three months ended in Mar. 2026 was €-20.1 Mil. Varex Imaging spent €20.1 Mil paying down its debt.

4. Net Issuance of Preferred Stock:
A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares. If this number is positive, it means that the company has received more cash from issuing preferred shares than it has paid to buy back preferred shares. If this number is negative, it means that company has paid more cash to buy back preferred shares than it has received for issuing preferred shares.

Varex Imaging's net issuance of preferred for the three months ended in Mar. 2026 was €0.0 Mil. Varex Imaging paid €0.0 Mil more to buy back preferred shares than it received from issuing preferred shares.

5. Cash Flow for Dividends:
Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.

Varex Imaging's cash flow for dividends for the three months ended in Mar. 2026 was €0.0 Mil. Varex Imaging received €0.0 Mil from paying cash dividends to shareholders.

6. Other Financing:
Money spent or earned by company from other financial activities.

Varex Imaging's other financing for the three months ended in Mar. 2026 was €-5.3 Mil. Varex Imaging spent €5.3 Mil on other financial activities.


Varex Imaging Cash Flow from Financing Related Terms


Varex Imaging Cash Flow from Financing Historical Data

* Premium members only.

The historical data trend for Varex Imaging's Cash Flow from Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Varex Imaging Cash Flow from Financing Chart

Varex Imaging Annual Data
Trend Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24 Sep25
Cash Flow from Financing
Get a 7-Day Free Trial Premium Member Only Premium Member Only -27.46 -24.04 -0.19 -2.97 -64.67

Varex Imaging Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cash Flow from Financing Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.65 -174.44 0.94 -1.37 -25.34
FRA:VI4
70GF Score
Varex Imaging Corp FRA:VI4
Cash Flow from Financing is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Varex Imaging Cash Flow from Financing Calculation

This is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders. In the calculation of free cash flow, cash from financing is not calculated because it is not related to operating activities.

Varex Imaging's Cash from Financing for the fiscal year that ended in Sep. 2025 is calculated as:

Varex Imaging's Cash from Financing for the quarter that ended in Mar. 2026 is:


Cash Flow from Financing for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €-200.2 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Cash Flow from Financing of €-200.2 Mil mean?
Varex Imaging (FRA:VI4) has a Cash Flow from Financing of €-200.2 Mil as of Mar. 2026. Cash Flow from Financing is the amount of cash earned or paid from financing operations. View historical data for Varex Imaging and its competitors.
Is Varex Imaging's Cash Flow from Financing too high?
Varex Imaging's current Cash Flow from Financing is €-200.2 Mil. Overall, Varex Imaging has a GF Score™ of 70/100, reflecting its overall financial health beyond just this single metric.
How does Varex Imaging's Cash Flow from Financing compare to OFIX and VMD?
Varex Imaging's Cash Flow from Financing of €-200.2 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash Flow from Financing for a Medical Devices & Instruments company?
A good Cash Flow from Financing depends on the Medical Devices & Instruments industry context. However, Cash Flow from Financing should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash Flow from Financing mean?
A high Cash Flow from Financing can signal that a stock is expensive relative to its fundamentals. Cash Flow from Financing is the amount of cash earned or paid from financing operations. View historical data for Varex Imaging and its competitors. Varex Imaging's current Cash Flow from Financing is €-200.2 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Varex Imaging stock overvalued right now?
Varex Imaging (FRA:VI4) has a current Cash Flow from Financing of €-200.2 Mil. The stock's GF Value™ is €11.41, compared to a current price of €10.20 — trading 10.6% below its estimated fair value. The current Cash Flow from Financing is €-200.2 Mil. Varex Imaging's overall GF Score™ is 70/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash Flow from Financing calculated?
Cash Flow from Financing is calculated from a company's financial statements. For Varex Imaging (FRA:VI4), the current Cash Flow from Financing is €-200.2 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Varex Imaging (FRA:VI4) Overvalued in 2026?

Based on GuruFocus' analysis, Varex Imaging stock appears to be undervalued. The current stock price of €10.20 is trading 10.6% below its estimated GF Value™ of €11.41.

Key valuation signals for FRA:VI4:

  • Cash Flow from Financing: €-200.2 Mil
  • GF Value™: €11.41 vs. price of €10.20 (10.6% below fair value)
  • GF Score™: 70/100 with 3 warning signs

No single metric tells the full story. See the FRA:VI4 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Varex Imaging Business Description

Other Exchanges VREX:USA
Address 1678 S. Pioneer Road, Salt Lake City, UT, USA, 84104
Varex Imaging Corp Designs, manufactures, sells, and services X-ray imaging components, including X-ray tubes, detectors, ionization chambers, high-voltage connectors, software, collimators, generators, exposure control devices, and heat exchangers.. The company operates through two segments: Medical, the key revenue driver, providing X-ray imaging components and accessories for healthcare applications, and Industrial, which provides Linatron X-ray accelerators, X-ray tubes, flat panel detectors, high-voltage connectors, and coolers for non-medical use. Geographically, it generates the majority of its revenue from Europe, the Middle East, and Africa (EMEA), with the rest coming from the Americas and Asia Pacific.
70GF Score

Get the complete analysis for FRA:VI4

Cash Flow from Financing is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€10.20
Price
€11.41
GF Value